What You Should Know:
- A new report by Accenture, "Reinventing R&D in the Age of AI," paints a clear picture: the biopharmaceutical industry stands at a critical juncture. Companies that embrace intelligent technologies like AI and machine learning are poised to become the future's leaders, while those clinging to outdated methods risk falling behind.
- Accenture's report serves as a roadmap, offering valuable insights and practical steps for companies ready to embrace the
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
VenoStent Raises $20M for Dialysis Solution, Secures $3.6M NIH Grant for U.S. Dialysis Therapeutic Clinical Trial
What You Should Know:
- VenoStent, Inc., a medical device company pioneering a new approach to improve dialysis patient outcomes, announced the successful completion of its Series A funding round. The round closed at $20M, with Norwest Venture Partners contributing an additional $4M to join Good Growth Capital and IAG Capital Partners as co-leads.
- VenoStent also welcomes Dr. Zack Scott, Norwest General Partner, and Dr. Ehi Akhirome, Norwest Investor, to its board of
Read More
Clinical Trial Diversity: Pharma Takes Action to Address Disparities
What You Should Know:
- Trinity Life Sciences, a leader in global life sciences commercialization solutions, has released a new white paper titled "Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA's Latest Guidance."
- The paper sheds light on the critical issue of racial and ethnic diversity in clinical trials, exploring current industry initiatives, their effectiveness, and the future landscape shaped by the FDA's evolving
Read More
How Vertical Commercial Optimization Platforms Help Pharma Companies Do Omnichannel Marketing Right
In a world full of options, companies need to compete on every prospect and existing customer. As the number of potential channels to reach customers increases, companies need to build strategies for interacting with the right customers, through the right channels, at the right time and with the right messages. Omnichannel marketing has emerged as an effective and efficient means for optimizing this customer engagement. However, while omnichannel is far from being simple in any industry, it
Read More
Proscia and Nucleai Partner to Integrate Predictive Biomarker Solutions
What You Should Know:
- Proscia, a leader in artificial intelligence (AI)-powered pathology solutions, and Nucleai, a leading spatial AI biomarker company, announced a strategic partnership today. This collaboration aims to revolutionize precision medicine by integrating Nucleai's advanced biomarker technology with Proscia's Concentriq® software platform.
- By harnessing the power of AI and digital pathology, this partnership offers the potential to fundamentally improve the
Read More
PwC: Pharma & Biotech Dealmaking Heats Up Despite Uncertainties
What You Should Know:
- The pharmaceutical and life sciences (PLS) sector is experiencing a resurgence in dealmaking activity, with a 20% increase in deal volume over the past year reported, according to PwC’s latest US Midyear Deals 2024 Outlook for Pharmaceutical and Life Sciences.
- M&A activity in the PLS sector is expected to remain strong throughout 2024 and potentially into 2025. Clarity on factors like US election outcomes and Federal Reserve interest rate decisions
Read More
Sanofi and Biovac Join Forces to Manufacture Polio Vaccines in Africa
What You Should Know:
- Sanofi, a global healthcare leader, and Biovac, a prominent South African biopharmaceutical company, announced a landmark partnership. This collaboration aims to establish local manufacturing of inactivated polio vaccines (IPV) in Africa, serving the needs of over 40 African countries.
- Under this new partnership, Sanofi will continue producing the bulk IPV supply. Biovac, upon receiving marketing authorization, will oversee the final stages of formulation,
Read More
Aranscia and SignatureRX Partner to Optimize GLP-1 Medication Use
What You Should Know:
- Aranscia, a leader in personalized diagnostics, and Signature RX, a prominent pharmacy supplier, announced a collaborative effort to improve the effectiveness of GLP-1 medications.
- The multi-phase partnership focuses on developing personalized treatment plans and ensuring consistent access to these crucial medications.
GLP-1s: Beyond Type 2 Diabetes
Glucagon-like peptide-1 receptor agonists (GLP-1s) were initially developed for type 2 diabetes
Read More
Boston Scientific Acquires Silk Road Medical for $1.16B, Bolstering Stroke Prevention
What You Should Know:
- Boston Scientific Corporation (NYSE: BSX) announced a definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK) for approximately $1.16 billion ($27.50 per share). Silk Road Medical is a leading innovator in minimally invasive stroke prevention technologies for patients with carotid artery disease.
- The acquisition strengthens Boston Scientific's position in the vascular medicine field, offering physicians a broader range of solutions for
Read More
Athos Therapeutics Taps Vultr Cloud GPU to Power AI Drug Discovery Engine
What You Should Know:
- Vultr, the world’s largest, privately-held cloud computing platform, today announced that Athos Therapeutics, Inc. (“Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training, tuning, and inference.
- Powered by NVIDIA HGX H100 systems and running on Dell
Read More
